Drug Information Rounds

Moses AM Miller M . Drug-induced dilutional hyponatremia. N Engl J Med 1974; 291: 1234–9.

Luzecky MH Burman KD Schultz ER . The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration. South Med J 1974; 67: 495–7.

Ajlouni K Kern MW Tures JF Theil GB Hagen TC . Thiothixene-in-duced hyponatremia. Arch Intern Med 1974; 134: 1103–5.

Sandifer MG . Hyponatremia due to psychotropic drugs. J Clin Psychiatry 1983; 44: 301–3.

Pledger DR Mathew H . Hyponatremia and clomipramine therapy. Br J Psychiatry 1989; 154: 263–4.

Balestrieri G Cerudelli B Ciaccio S Rizzoni D . Hyponatremia and seizure due to overdose of trazodone (letter). BMJ 1992; 304: 686.

Blacksten JV Birt JA . Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine. Ann Pharmacother 1993; 27: 723–4.

Kazal LA Jr Hall DL Miller LG Noel ML . Fluoxetine-induced SIADH: A geriatric occurrence? J Fam Pract 1993; 36: 341–3.

Vishwanath BM Navalgund AA Cusano W Navalgund KA . Fluoxetine as a cause of SIADH (letter). Am J Psychiatry 1991; 148: 542–3.

Marik PE van Heerden W Steenkamp V . Fluoxetine-induced syndrome of inappropriate antidiuretic hormone excretion (letter). S Afr Med J 1990; 78: 760–1.

Cohen BJ Mahelsky M Adler L . More cases of SIADH with fluoxetine (letter). Am J Psychiatry 1990; 147: 948–9.

Staab JP Yerkes SA Cheney EM Clayton AH . Transient SIADH associated with fluoxetine (letter). Am J Psychiatry 1990; 147: 1569–70.

Hwang AS Magraw RM . Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine (letter). Am J Psychiatry 1989: 146: 399.

Gommans JH Edwards RA . Fluoxetine and hyponatremia (letter). N Z MedJ 1990; 103: 106.

Jackson C Carson W Markowitz J Mintzer J . SIADH associated wtih fluoxetine and sertraline therapy (letter). Am J Psychiatry 1995; 152: 809–10.

Druckenbrod R Mulsant BH . Fluoxetine-induced syndrome of inappropriate antidiuretic hormone secretion: A geriatric case report and a review of the literature. J Geriatr Psychiatry Neurol 1994; 7: 255–8.

Goddard C Paton C . Hyponatraemia associated with paroxetine (letter). BMJ 1992; 305: 1332.

Chua TP Vong SK . Hyponatraemia associated with paroxetine (letter). BMJ 1993; 306: 143.

Ayonrinde OT Reutens SG Sanfilippo FM . Paroxetine-induced SIADH (letter). Med J Aust 1995; 163: 390.

Chua TP Vong SK . Paroxetine and hyponatraemia (letter). Br J Clin Pract 1994; 48: 49.

Doshi D Borison R . Association of transient SIADH with sertraline (letter). Am J Psychiatry 1994; 151: 779–80.

Crews JR Potts NLS Schreiber J Lipper S . Hyponatremia in a patient with sertraline (letter). Am J Psychiatry 1993; 150: 1564.

Bluff DD Oji N . SIADH in a patient receiving sertraline (letter). Ann Intern Med 1995; 123: 811.

Llorente MD Gorelick M Silverman MA . Sertraline as the cause of inappropriate antidiuretic hormone secretion (letter). J Clin Psychiatry 1994; 55: 543–4.

Thornton SL Resch DS . SIADH associated with sertraline therapy (letter). Am J Psychiatry 1995; 152: 809.

Baliga RR McHardy KC . Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy. Br J Clin Pract 1993; 47: 62–3.

Bartter FC Schwartz WB . The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967; 42: 790–806.

Riggs AT Dysken MW Kim SW Opsahl JA . A review of disorders of water homeostasis in psychiatric patients. Psychosomatics 1991; 32: 133–48.

Kovacs L Robertson GL . Syndrome of inappropriate antidiuresis. Endocrinol Metab Clin North Am 1992; 21: 859–75.

Leaf A Bartter FC Santos RF Wrong O . Evidence in man that urinary electrolyte loss induced by Pitressin is a function of water retention. J Clin Invest 1953; 32: 868–78.

Moses AM Miller M Streeten DH . Pathophysiologic and pharmacologic alterations in the release and action of ADH. Metabolism 1976; 25: 697–721.

Goldstein CS Braunstein S Goldfarb S . Idiopathic syndrome of inappropriate antidiuretic hormone secretion possibly related to advanced age. Ann Intern Med 1983; 99: 185–8.

Edwards MS Baker CJ . Streptococcus agalactiae (group B streptococcus). In: Mandell GL Bennett JE Dolin R , eds. Principles and practice of infectious disease. 4th ed. New York: Livingstone, 1995; 1835–45.

Report of the Committee on Infectious Disease. Group B streptococcal infections. In: 1994 Red book. Elk Grove Village, IL: American Academy of Pediatrics, 1994; 439–42.

Thomsen AC Morup L Brogaard-Hansen K . Antibiotic elimination of group B streptococci in urine in prevention of preterm labour. Lancet 1987; 1: 591–3.

Group B streptococcal infections in pregnancy. ACOG Tech Bull 1992; 170 (July): 1–5.

Towers CV . Group B Streptococcus: The US controversy. Lancet 1995; 346: 197–8.

Pyati SP Pildes RS Jacobs NM Ramamurthy RS Yeh TF Raval DS . Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease. N Engl J Med 1983; 308: 1383–8.

Morales WJ Lim DV Walsh AF . Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis. Am J Obstet Gynecol 1986; 155: 979–83.

Boyer KM Gotoff SP . Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665–9.

Garland SM Fliegner JR . Group B Streptococcus and neonatal infections: The case of intrapartum chemoprophylaxis. Aust N Z Obstet Gynaecol 1991; 31: 119–22.

Klebanoff MA Regan JA Rao AV Nugent RP Blackwelder WC Eschenbach WC . Outcome of the Vaginal Infections and Prematurity Study: Results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol 1995; 172: 1540–5.

Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Morb Mortal Wkly Rep 1996; 45 (RR-7): 1–24.

Tuppurainen N Hallman M . Prevention of neonatal group B streptococcal disease: Intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989; 73: 585–7.

Walsh J Hutchins S . Group B streptococcal disease: Its importance in the developing world and prospect for prevention with vaccines. Pediatr Infect Dis J 1989; 8: 271–7.

Erramouspe J Lourwood DL . Neonatal group B streptococcal infection prevention. Ann Pharmacother 1994; 28: 474–5.

D'amico G . The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709–27.

Ibels LS Gyory AZ . IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 1994; 73: 79–102.

Bennett WM Wilker RG Kincaid-Smith P . Treatment of IgA nephropathy with eicosapentanoic acid (EPA): A two-year prospective trial. Clin Nephrol 1989; 31: 128–31.

Cheng IKP Chan PCK Chan MK . The effect of fish oil dietary supplement on the progression of mesangial IgA glomerulonephritis. Nephrol Dial Transplant 1990; 5: 241–6.

Donadio JV Bergstralh EJ Offord KP Holley KE Spencer DC , Mayo Nephrology Collaborative Group. Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Clin Nephrol 1994; 41: 65–71.

Pettersson EE Rekola S Berglund L Sundqvist KG Angelin B Diczfalusy U . Treatment of IgA nephropathy with omega-3-poly-unsat-urated fatty acids: A prospective, double-blind, randomized study. Clin Nephrol 1994; 41: 183–90.

Donadio JV Bergstralh EJ Offord KP Spencer DC Holley KE , Mayo Nephrology Collaborative Group. A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994; 331: 1194–9.

Hamazaki T Tateno S Shishido H . Eicosapentanoic acid and IgA nephropathy. Lancet 1984; 1: 1017–8.

Donadio JV . Omega-3 polyunsaturated fatty acids: A potential new treatment of immune renal disease. Mayo Clin Proc 1991; 66: 1018–28.

De Strihou CV . Fish oil for IgA nephropathy. N Engl J Med 1994; 331: 1227–9.

Julian BA Waldo FB Rifai A Mestecky J . IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 1988; 84: 129–32.

Hogg RJ , Scientific Planning Committee of the IgA Nephropathy Study. A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Am J Kidney Dis 1995; 26: 792–6.

Clark WF Parbtani A Naylor CD Levinton CM Muirhead N Spanner E . Fish oil in lupus nephritis: Clinical findings and methodological implications. Kidney Int 1993; 44: 75–86.

Holman RT Johnson SB Bibus D Spencer DC Donadio JV . Essential fatty acid deficiency profiles in idiopathic immunoglobulin A nephropathy. Am J Kidney Dis 1994; 23: 648–54.

Mueller BA Talbert RL . Biological mechanisms and cardiovascular effects of omega-3 fatty acids. Clin Pharm 1988; 7: 795–807.

Olin BR Hebel S , eds. Facts and comparisons: loose-leaf drug information service.. St. Louis: Facts and Comparisons, Inc., 1996: 54e-f.

Mueller BA Talbert RL Tegeler CH Prihoda TJ . The bleeding time effects of a single dose of aspirin in subjects receiving omega-3 fatty acid dietary supplementation. J Clin Pharmacol 1991; 31: 185–90.